{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:18:58Z","timestamp":1792034338374,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018570","name":"Special Project of Central Government for Local Science and Technology Development of Hubei Province","doi-asserted-by":"publisher","award":["2022ZY0050"],"award-info":[{"award-number":["2022ZY0050"]}],"id":[{"id":"10.13039\/501100018570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22365022"],"award-info":[{"award-number":["22365022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Inner Mongolia Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2022QN03014"],"award-info":[{"award-number":["2022QN03014"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020788","name":"Science and Technology Major Project of Inner Mongolia Autonomous Region of China","doi-asserted-by":"publisher","award":["2023YFHH0010"],"award-info":[{"award-number":["2023YFHH0010"]}],"id":[{"id":"10.13039\/501100020788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117522","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:58:54Z","timestamp":1742356734000},"page":"117522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Elucidating the dual mechanistic action and synergism of platinum complexes bearing valproic acid as leaving ligand on NF-\u03baB and inflammatory pathways in glioma"],"prefix":"10.1016","volume":"290","author":[{"given":"Shad","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fufu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Jamil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-8881","authenticated-orcid":false,"given":"Faiz-Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejmech.2025.117522_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117522_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nec.2012.01.007","article-title":"Temozolomide and other potential agents for the treatment of glioblastoma multiforme","volume":"23","author":"Nagasawa","year":"2012","journal-title":"Neurosurg. Clin."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41435-021-00161-5","article-title":"Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma","volume":"23","author":"Decraene","year":"2022","journal-title":"Gene Immun."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117522_bib4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.drudis.2019.03.008","article-title":"Therapy for glioblastoma: is it working?","volume":"24","author":"Zanders","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117522_bib5","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","article-title":"NF-\u03baB role on tumor proliferation, migration, invasion and immune escape","volume":"31","author":"Khan","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10143-024-02783-5","article-title":"Interleukin 6 and cancer resistance in glioblastoma multiforme","volume":"47","author":"Detchou","year":"2024","journal-title":"Neurosurg. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-024-03019-6","article-title":"Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas","volume":"43","author":"Tuysuz","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117522_bib8","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-020-03524-9","article-title":"P53 vs NF-\u03baB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa","volume":"77","author":"Carr\u00e0","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17376-0","article-title":"Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-\u03baB and p53 signaling pathways","volume":"7","author":"Ullah","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117522_bib10","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/bab.2233","article-title":"Caspase-3: structure, function, and biotechnological aspects","volume":"69","author":"Asadi","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ejmech.2025.117522_bib11","first-page":"21","article-title":"Chapter Two - a caspase-3 activatable photoacoustic probe for in vivo imaging of tumor apoptosis","volume":"vol. 657","author":"Wang","year":"2021"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/cr.2010.168","article-title":"Regulation of NF-\u03baB signaling by caspases and MALT1 paracaspase","volume":"21","author":"Staal","year":"2011","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117522_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41419-022-05156-2","article-title":"Apoptotic caspase inhibits innate immune signaling by cleaving NF-\u03baBs in both Mammals and Flies","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117522_bib14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41551-021-00728-7","article-title":"Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance","volume":"5","author":"Wang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117522_bib15","doi-asserted-by":"crossref","first-page":"e1505","DOI":"10.1038\/cddis.2014.465","article-title":"Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo","volume":"5","author":"Rocha","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117522_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinorgbio.2016.11.032","article-title":"Synthesis, characterization, DNA interactions and antiproliferative activity on glioblastoma of iminopyridine platinum(II) chelate complexes","volume":"168","author":"Posadas","year":"2017","journal-title":"J. Inorg. Biochem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117522_bib17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/nano13101619","article-title":"Platinum-based nanoformulations for glioblastoma treatment: the resurgence of platinum drugs?","volume":"13","author":"Alfonso-Triguero","year":"2023","journal-title":"Nanomaterials"},{"issue":"20","key":"10.1016\/j.ejmech.2025.117522_bib18","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1200\/JCO.2002.08.087","article-title":"High response rate to cisplatin\/etoposide regimen in childhood low-grade glioma","volume":"20","author":"Massimino","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2025.117522_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/B:NEON.0000013479.64348.69","article-title":"Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients","volume":"66","author":"Silvani","year":"2004","journal-title":"J. Neuro Oncol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117522_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11060-020-03549-x","article-title":"Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma","volume":"148","author":"Nellan","year":"2020","journal-title":"J. Neuro Oncol."},{"issue":"17","key":"10.1016\/j.ejmech.2025.117522_bib21","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/1078-0432.CCR-20-0768","article-title":"Phase I trial of expanded, activated autologous NK-cell infusions with trastuzumab in patients with HER2-positive cancers","volume":"26","author":"Lee","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117522_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1517\/14728222.2015.1043269","article-title":"Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy","volume":"19","author":"Chen","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep28474","article-title":"Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes","volume":"6","author":"Brabec","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117522_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2217\/fon.15.22","article-title":"Molecular targets in glioblastoma","volume":"11","author":"Zorzan","year":"2015","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nurt.2006.11.007","article-title":"Valproic acid: second generation","volume":"4","author":"Bialer","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117522_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02479423","article-title":"Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad","volume":"18","author":"Sawa","year":"2001","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.ejmech.2025.117522_bib27","first-page":"23","article-title":"Chapter 2 - the therapeutic and neuroprotective effects of an antiepileptic drug valproic acid in glioma patients","volume":"vol. 258","author":"Li","year":"2020"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117522_bib28","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117522_bib29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s10571-020-00930-2","article-title":"Valproic acid sensitizes glioma cells to luteolin through induction of apoptosis and autophagy via akt signaling","volume":"41","author":"Han","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117522_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10050968","article-title":"Different effects of valproic acid on SLC12A2, SLC12A5 and SLC5A8 gene expression in pediatric glioblastoma cells as an approach to personalised therapy","volume":"10","author":"Damanskien\u0117","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.117522_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.687362","article-title":"Valproic acid: a promising therapeutic agent in glioma treatment","volume":"11","author":"Han","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117522_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/genes9110522","article-title":"Valproic acid inhibits proliferation and reduces invasiveness in glioma stem cells through wnt\/\u03b2 catenin signalling activation","volume":"9","author":"Riva","year":"2018","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117522_bib33","doi-asserted-by":"crossref","first-page":"18577","DOI":"10.18632\/oncotarget.14612","article-title":"Advances in epigenetic glioblastoma therapy","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117522_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8884320","article-title":"Valproate sodium protects blood brain barrier integrity in intracerebral hemorrhage mice","volume":"2020","author":"Zhao","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","article-title":"Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition","volume":"31","author":"Wang","year":"2011","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejmech.2025.117522_bib36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1528-1157.1994.tb02535.x","article-title":"Simultaneous and continuous measurement of free concentration of valproate in blood and extracellular space of rat cerebral cortex","volume":"35","author":"L\u00fccke","year":"2005","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117522_bib37","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1159\/000447912","article-title":"Valproic acid promotes human glioma U87 cells apoptosis and inhibits glycogen synthase kinase-3\u03b2 through ERK\/akt signaling","volume":"39","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117522_bib38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1349-7006.2008.00793.x","article-title":"Valproic acid resensitizes cisplatin-resistant ovarian cancer cells","volume":"99","author":"Lin","year":"2008","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.09.018","article-title":"Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer","volume":"329","author":"Diyabalanage","year":"2013","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117522_bib40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jinorgbio.2011.03.003","article-title":"Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes","volume":"105","author":"Griffith","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.117522_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113689","article-title":"Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM\/LDHA and CCND1\/BCL2\/ATG3 signaling pathways","volume":"224","author":"Bai","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117522_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113920","article-title":"Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: ascribe possibilities of new antitumor strategies","volume":"227","author":"Bai","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117522_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfac053","article-title":"Vitamin B6 based Pt(II) complexes: biomolecule derived potential cytotoxic agents for thyroid cancer","volume":"14","author":"Ming","year":"2022","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmech.2025.117522_bib44","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejmech.2018.12.052","article-title":"ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway","volume":"164","author":"Rahman","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2025.117522_bib45","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-14-0247","article-title":"Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes","volume":"74","author":"Hall","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117522_bib46","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ica.2008.03.117","article-title":"[1H,15N] NMR studies of the aquation of cis-diamine platinum(II) complexes","volume":"362","author":"Cubo","year":"2009","journal-title":"Inorg. Chim. Acta."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.117522_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113689","article-title":"Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM\/LDHA and CCND1\/BCL2\/ATG3 signaling pathways","volume":"224","author":"Bai","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117522_bib49","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41388-018-0546-z","article-title":"Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor","volume":"38","author":"Zepecki","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s42003-024-06052-5","article-title":"Platinum iodido drugs show potential anti-tumor activity, affecting cancer cell metabolism and inducing ROS and senescence in gastrointestinal cancer cells","volume":"7","author":"Melones-Herrero","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.117522_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejps.2016.01.019","article-title":"Quercetin derivative induces cell death in glioma cells by modulating NF-\u03baB nuclear translocation and caspase-3 activation","volume":"84","author":"Kiekow","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"suppl_4","key":"10.1016\/j.ejmech.2025.117522_bib52","first-page":"iv20","article-title":"P01.10 Effects of valproic acid on NF-\u03baB signaling in glioblastoma","volume":"18","author":"Berendsen","year":"2016","journal-title":"Neuro Oncol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117522_bib53","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1055\/s-0042-1758864","article-title":"Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis","volume":"80","author":"Wang","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1501292","article-title":"Targeting NF-\u03baB in glioblastoma: a therapeutic approach","volume":"2","author":"Friedmann-Morvinski","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117522_bib55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.omto.2022.08.007","article-title":"TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I","volume":"26","author":"Fei","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ejmech.2025.117522_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109369","article-title":"Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence","volume":"118","author":"Zhou","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117522_bib57","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/mc.22240","article-title":"IL-6, IL-8, MMP-2, MMP-9 are overexpressed in Fanconi anemia cells through a NF-\u03baB\/TNF-\u03b1 dependent mechanism","volume":"54","author":"Epanchintsev","year":"2015","journal-title":"Mol. Carcinog."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117522_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134584","article-title":"RIP1 is a novel component of \u03b3-ionizing radiation-induced invasion of non-small cell lung cancer cells","volume":"21","author":"Kang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117522_bib59","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1158\/0008-5472.CAN-08-4079","article-title":"The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma","volume":"69","author":"Park","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117522_bib60","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1038\/s41467-021-23832-3","article-title":"Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117522_bib61","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1021\/acs.jmedchem.4c01699","article-title":"In vitro and in vivo anticancer activities of water-soluble Ru(II)(\u03b76-p-cymene) complexes via activating apoptosis central regulators and possibilities of new antitumor strategies in triple negative breast cancers","volume":"68","author":"Man","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:15Z","timestamp":1777529295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":61,"alternative-id":["S0223523425002879"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117522","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the dual mechanistic action and synergism of platinum complexes bearing valproic acid as leaving ligand on NF-\u03baB and inflammatory pathways in glioma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117522"}}